QBIOTICS WELCOMES STEPHEN DOYLE AS CHIEF EXECUTIVE OFFICER
05 Aug 2024 //
PR NEWSWIRE
Qbiotics To Present At Sachs 9Th Annual Immuno-Oncology Innovation Forum
31 May 2023 //
PR NEWSWIRE
New Cancer Treatment For APVMA Approval Of Qbiotics` Stelfonta®
07 Jul 2021 //
PR NEWSWIRE
New Cancer Treatment For APVMA Approval Of Qbiotics` Stelfonta®
07 Jul 2021 //
PR NEWSWIRE
QBiotics enters agreement with MSD to evaluate Tigilanol Tiglat in combo
14 Aug 2020 //
PHARMABIZ
QBiotics Announces Clinical Collaboration with MSD Targeting Melanoma
12 Aug 2020 //
PRNEWSWIRE